# Jones Lang Lasalle Inc: financial statements, quarterly

JLL · NYSE · CIK 1037976 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jll.md) · [Financials](/companies/jll/financials.md) · [Filings](/companies/jll/filings.md) · [Insiders](/companies/jll/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jll/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,111](/filings/0001037976-24-000044.md) | [5,881 d](/filings/0001037976-26-000037.md) | [5,125](/filings/0001037976-25-000025.md) | [5,629](/filings/0001037976-25-000045.md) | [5,869](/filings/0001037976-25-000071.md) | [6,811 d](/filings/0001037976-26-000037.md) | [5,746](/filings/0001037976-26-000106.md) | [6,250](/filings/0001037976-26-000152.md) | [6,510](/filings/0001037976-25-000071.md) | [7,609 d](/filings/0001037976-26-000037.md) | [6,387](/filings/0001037976-26-000106.md) | [6,928](/filings/0001037976-26-000152.md) |
| Operating income | $m | [119](/filings/0001037976-24-000044.md) | [290 d](/filings/0001037976-26-000037.md) | [114](/filings/0001037976-25-000025.md) | [152](/filings/0001037976-25-000045.md) | [228](/filings/0001037976-25-000071.md) | [373 d](/filings/0001037976-26-000037.md) | [120](/filings/0001037976-26-000106.md) | [197](/filings/0001037976-26-000152.md) | [274](/filings/0001037976-25-000071.md) | [507 d](/filings/0001037976-26-000037.md) | [205](/filings/0001037976-26-000106.md) | [291](/filings/0001037976-26-000152.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [14.5](/filings/0001037976-24-000044.md) | [12.7 d](/filings/0001037976-26-000037.md) | [15.9](/filings/0001037976-25-000025.md) | [20.5](/filings/0001037976-25-000045.md) | [37.4](/filings/0001037976-25-000071.md) | [58.7 d](/filings/0001037976-26-000037.md) | [14.0](/filings/0001037976-26-000106.md) | [26.7](/filings/0001037976-26-000152.md) | [52.6](/filings/0001037976-25-000071.md) | [96.2 d](/filings/0001037976-26-000037.md) | [38.1](/filings/0001037976-26-000106.md) | [51.3](/filings/0001037976-26-000152.md) |
| Net income | $m | [59.7](/filings/0001037976-24-000044.md) | [172 d](/filings/0001037976-26-000037.md) | [66.1](/filings/0001037976-24-000021.md) | [84.4](/filings/0001037976-24-000035.md) | [155](/filings/0001037976-24-000044.md) | [241 d](/filings/0001037976-26-000037.md) | [57.5](/filings/0001037976-26-000106.md) | [111](/filings/0001037976-26-000152.md) | [222](/filings/0001037976-25-000071.md) | [402 d](/filings/0001037976-26-000037.md) | [159](/filings/0001037976-26-000106.md) | [214](/filings/0001037976-26-000152.md) |
| Diluted EPS | $ per share | [1.23](/filings/0001037976-24-000044.md) | not reported | [1.37](/filings/0001037976-25-000025.md) | [1.75](/filings/0001037976-25-000045.md) | [3.20](/filings/0001037976-25-000071.md) | not reported | [1.14](/filings/0001037976-26-000106.md) | [2.32](/filings/0001037976-26-000152.md) | [4.61](/filings/0001037976-25-000071.md) | not reported | [3.33](/filings/0001037976-26-000106.md) | [4.59](/filings/0001037976-26-000152.md) |
| Basic EPS | $ per share | [1.25](/filings/0001037976-24-000044.md) | not reported | [1.39](/filings/0001037976-25-000025.md) | [1.77](/filings/0001037976-25-000045.md) | [3.26](/filings/0001037976-25-000071.md) | not reported | [1.17](/filings/0001037976-26-000106.md) | [2.36](/filings/0001037976-26-000152.md) | [4.71](/filings/0001037976-25-000071.md) | not reported | [3.40](/filings/0001037976-26-000106.md) | [4.66](/filings/0001037976-26-000152.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001037976-23-000045.md) | [0.4](/filings/0001037976-25-000006.md) | [0.4](/filings/0001037976-24-000021.md) | [0.4](/filings/0001037976-24-000035.md) | [0.4](/filings/0001037976-24-000044.md) | [0.4](/filings/0001037976-26-000037.md) | [0.4](/filings/0001037976-25-000025.md) | [0.4](/filings/0001037976-25-000045.md) | [0.4](/filings/0001037976-25-000071.md) | [0.6](/filings/0001037976-26-000152.md) | [0.4](/filings/0001037976-26-000106.md) | [0.5](/filings/0001037976-26-000152.md) |
| Current assets | $bn | [6.4](/filings/0001037976-23-000045.md) | [6.9](/filings/0001037976-25-000006.md) | [6.3](/filings/0001037976-24-000021.md) | [6.6](/filings/0001037976-24-000035.md) | [8.4](/filings/0001037976-24-000044.md) | [7.5](/filings/0001037976-26-000037.md) | [7.2](/filings/0001037976-25-000025.md) | [7.9](/filings/0001037976-25-000045.md) | [7.6](/filings/0001037976-25-000071.md) | [8.2](/filings/0001037976-26-000152.md) | [8.3](/filings/0001037976-26-000106.md) | [7.8](/filings/0001037976-26-000152.md) |
| Total assets | $bn | [15.5](/filings/0001037976-23-000045.md) | [16.1](/filings/0001037976-25-000006.md) | [15.5](/filings/0001037976-24-000021.md) | [15.9](/filings/0001037976-24-000035.md) | [17.8](/filings/0001037976-24-000044.md) | [16.8](/filings/0001037976-26-000037.md) | [16.6](/filings/0001037976-25-000025.md) | [17.3](/filings/0001037976-25-000045.md) | [17.2](/filings/0001037976-25-000071.md) | [17.8](/filings/0001037976-26-000152.md) | [17.9](/filings/0001037976-26-000106.md) | [17.5](/filings/0001037976-26-000152.md) |
| Current liabilities | $bn | [5.4](/filings/0001037976-23-000045.md) | [6.4](/filings/0001037976-25-000006.md) | [5.1](/filings/0001037976-24-000021.md) | [5.5](/filings/0001037976-24-000035.md) | [8.0](/filings/0001037976-24-000044.md) | [7.1](/filings/0001037976-26-000037.md) | [6.6](/filings/0001037976-25-000025.md) | [7.2](/filings/0001037976-25-000045.md) | [7.0](/filings/0001037976-25-000071.md) | [7.4](/filings/0001037976-26-000152.md) | [7.4](/filings/0001037976-26-000106.md) | [7.0](/filings/0001037976-26-000152.md) |
| Total liabilities | $bn | [9.3](/filings/0001037976-23-000045.md) | [9.7](/filings/0001037976-25-000006.md) | [9.1](/filings/0001037976-24-000021.md) | [9.4](/filings/0001037976-24-000035.md) | [11.0](/filings/0001037976-24-000044.md) | [9.9](/filings/0001037976-26-000037.md) | [9.7](/filings/0001037976-25-000025.md) | [10.2](/filings/0001037976-25-000045.md) | [9.9](/filings/0001037976-25-000071.md) | [10.2](/filings/0001037976-26-000152.md) | [10.5](/filings/0001037976-26-000106.md) | [9.9](/filings/0001037976-26-000152.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001037976-26-000152.md) | not reported | [0.2](/filings/0001037976-26-000152.md) |
| Short-term borrowings | $bn | [0.1](/filings/0001037976-23-000045.md) | [0.1](/filings/0001037976-24-000044.md) | [0.1](/filings/0001037976-24-000021.md) | [0.1](/filings/0001037976-24-000035.md) | [0.9](/filings/0001037976-24-000044.md) | [0.4](/filings/0001037976-25-000071.md) | [1.0](/filings/0001037976-25-000025.md) | [0.8](/filings/0001037976-25-000045.md) | [0.5](/filings/0001037976-25-000071.md) | [0.1](/filings/0001037976-26-000152.md) | [0.8](/filings/0001037976-26-000106.md) | [0.7](/filings/0001037976-26-000152.md) |
| Shareholders' equity | $bn | [6.0](/filings/0001037976-23-000045.md) | [6.3](/filings/0001037976-25-000006.md) | [6.3](/filings/0001037976-24-000021.md) | [6.4](/filings/0001037976-24-000035.md) | [6.6](/filings/0001037976-24-000044.md) | [6.8](/filings/0001037976-26-000037.md) | [6.8](/filings/0001037976-25-000025.md) | [7.0](/filings/0001037976-25-000045.md) | [7.2](/filings/0001037976-25-000071.md) | [7.5](/filings/0001037976-26-000152.md) | [7.3](/filings/0001037976-26-000106.md) | [7.5](/filings/0001037976-26-000152.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [326 d](/filings/0001037976-24-000044.md) | [729 d](/filings/0001037976-26-000037.md) | [(678)](/filings/0001037976-25-000025.md) | [274 d](/filings/0001037976-25-000045.md) | [262 d](/filings/0001037976-25-000071.md) | [927 d](/filings/0001037976-26-000037.md) | [(768)](/filings/0001037976-26-000106.md) | [333 d](/filings/0001037976-26-000152.md) | [617 d](/filings/0001037976-25-000071.md) | [1,012 d](/filings/0001037976-26-000037.md) | [(755)](/filings/0001037976-26-000106.md) | [488 d](/filings/0001037976-26-000152.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [19.9 d](/filings/0001037976-24-000044.md) | [22.2 d](/filings/0001037976-26-000037.md) | [20.0](/filings/0001037976-25-000025.md) | [20.4 d](/filings/0001037976-25-000045.md) | [20.0 d](/filings/0001037976-25-000071.md) | [20.3 d](/filings/0001037976-26-000037.md) | [19.7](/filings/0001037976-26-000106.md) | [40.2 d](/filings/0001037976-26-000152.md) | [70.3 d](/filings/0001037976-25-000071.md) | [81.3 d](/filings/0001037976-26-000037.md) | [300](/filings/0001037976-26-000106.md) | [109 d](/filings/0001037976-26-000152.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [49.7](/filings/0001037976-23-000030.md) | [48.6](/filings/0001037976-23-000045.md) | [48.3](/filings/0001037976-24-000035.md) | [48.4](/filings/0001037976-24-000044.md) | [48.3](/filings/0001037976-25-000025.md) | [48.3](/filings/0001037976-25-000045.md) | [48.5](/filings/0001037976-25-000071.md) | [48.4](/filings/0001037976-26-000106.md) | [48.3](/filings/0001037976-26-000152.md) | [48.3](/filings/0001037976-25-000071.md) | [47.8](/filings/0001037976-26-000106.md) | [46.9](/filings/0001037976-26-000152.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 46,007,703 at 2026-06-30, from the cover of the [10-Q filed 2026-07-30](/filings/0001037976-26-000152.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.